The latest reports on this polymorphism, cited in the meta-analysis of Wei and co-workers 2013, indicate a lack of dependence between GSTP1 Ile/Ile, Ile/Val, and Val/Val variants and an increased risk of prostate cancer. The gene discussed is GSTP1; the disease is prostate carcinoma.